Avalon GloboCare Partners with Saga Health for KetoAir Launch
Avalon GloboCare Corp. (NASDAQ: ALBT) has made a significant stride in health technology by entering a distribution agreement with Saga Health Corporation. This partnership aims to incorporate the innovative KetoAir™ breathalyzer into Saga Health's Holistic Health Reset Program, specifically designed for first responders seeking holistic wellness solutions.
About KetoAir™ and Its Benefits
The KetoAir™ is an advanced handheld breathalyzer that provides valuable insights into ketogenic health management by measuring breath acetone concentration (BrAce). This key indicator reflects fat metabolism and the state of ketosis in users. Ideal for individuals engaged in ketogenic diets for weight management, athletic performance, or therapeutic purposes, the KetoAir™ breathalyzer employs nano-sensor technology to ensure accuracy and immediacy in data.
Connectivity and Accessibility
The device enhances user experience by being compatible with both Apple and Android platforms, allowing users to seamlessly access the KetoAir™ application via the Apple App Store and Google Play Store. This feature facilitates the monitoring of dietary habits and metabolic health, promoting a lifestyle centered around wellness.
Avalon GloboCare's Vision and Future Plans
David Jin, M.D., Ph.D., President and CEO of Avalon GloboCare, expressed optimism about this partnership, envisioning it as a pivotal moment for the commercial rollout of KetoAir™. He highlighted the strong demand for real-time monitoring tools that cater to individuals embracing ketogenic lifestyles, reflecting Avalon’s commitment to delivering innovative health solutions.
Introduction of KetoAir™ into Holistic Health Programs
Saga Health, known for its comprehensive wellness journeys, aims to integrate KetoAir™ into its communication and engagement strategies for first responders. According to Thomas Tauzin, CEO of Saga Health, this collaboration is a leap towards equipping first responders with tools necessary for maintaining their health amidst demanding roles.
About Avalon GloboCare Corp.
Avalon GloboCare is dedicated to pioneering diagnostic consumer products while advancing its portfolio in cellular therapy. The company continues to work on expanding its applications for the KetoAir™ technology while also exploring further innovations in diagnostic health. As a Class I medical device registered with the U.S. Food and Drug Administration, the KetoAir™ is positioned to meet health regulations, ensuring reliability for users.
Saga Health's Holistic Approach
Saga Health supports various demographics through tailored wellness programs. By combining nutritional guidance and personalized tools like KetoAir™, their Holistic Health Reset Program actively engages individuals in improving health outcomes. This approach is designed to cater specifically to communities such as first responders who often face unique health challenges.
Important Contact Information
For those interested in more information, Avalon GloboCare can be contacted directly at:
Avalon GloboCare Corp.
4400 Route 9 South, Suite 3100
Freehold, NJ 07728
PR@Avalon-GloboCare.com
Investor Relations:
Crescendo Communications, LLC
Tel: (212) 671-1020 Ext. 304
albt@crescendo-ir.com
Frequently Asked Questions
What is the KetoAir™ device?
The KetoAir™ is a breathalyzer that measures breath acetone concentration, helping users monitor their ketogenic state.
How does the partnership with Saga Health benefit first responders?
The partnership allows for the introduction of KetoAir™ into health programs tailored specifically for first responders, enhancing their health management.
What technology does KetoAir™ use?
KetoAir™ utilizes nano-sensor technology for real-time monitoring of fat metabolism and ketosis.
Where can consumers find the KetoAir™ application?
The KetoAir™ app is available for download on the Apple App Store and Google Play Store.
What are Avalon GloboCare's broader goals?
Avalon GloboCare aims to expand its diagnostic capabilities through innovative products while focusing on health technology advancements.
